Overweight and obesity are established risk factors for the development of metabolic diseases, including diabetes, hypertension, dyslipidemia, and cardiovascular disease.
Environmental causes of T2D and other metabolic disorders are often overlooked; a new body of evidence, however, is changing the clinical thinking about mitigating these effects on those at high risk of T2D.
Barriers and strategies for medication adherence in youth with type 2 diabetes were found to be similar to those observed in youth with other chronic pediatric conditions.
Emerging evidence shows promise regarding the potential role of precision nutrition in the prevention and management of T2D. However, considerably more research is needed before this approach can be widely applied for these purposes.
Investigators examine whether urine metabolites in the tricarboxylic acid cycle can independently predict the risk for CKD progression in individuals with type 2 diabetes.
Investigators sought to determine whether bariatric surgery was associated with lower incidence of microvascular disease for patients with T2D and severe obesity.
The risk for cardiovascular events in patients with type 2 diabetes without manifest cardiovascular disease is primarily related to the severity of atherosclerosis.